Global Mice Model Market to surpass $ 11.7 Bn by 2025

January 14, 2020


According to the research report titled ‘Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global mice model market is expected to cross USD 11.7 billion by the year 2025.
 

According to the report, rising adoption of mice in order to develop advanced vaccines is a key factor driving the mice model market growth. Mice model is the use of mice to study the development and occurrences of diseases as mice have a genetic formation similar to humans. Mice are also used in mechanistic analysis of human reproduction. Increasing number of testing procedures on mice in order to ensure safe use of drugs in humans are aiding the expansion of the market.
 

Factors such as surging usage of mice for conducting research on cardiovascular diseases, autoimmune diseases, and cancer are stimulating the industry outlook. Rising consumption rates of personalized medicines is leading to surging demand for customized humanized mice models. Rising number of pipeline drugs has increased animal testing instances, for authenticating the safety and efficacy of novel drugs, thereby boosting the growth of the market.
 

As per mice type, the inbred mice model market segment held 27% share in the year 2018. Surging need for this type of model for cancer research is facilitating the business scenario.
 

In terms of technology, the CRISPER technology segment held 32.7% share in the mice model market in the year 2018. CRISPER technology based mice models offer benefits such as better efficiency, ease of use, cost-effectiveness, and time saving, thereby fueling the growth of the segment.
 

Based on application spectrum, the research & development mice model market segment held the largest share of over 71% in the year 2018. Mice models are used to measure and analyze the efficiency and safety of new vaccines and drugs which are entering the clinical phase. Rising R&D activities has led to development of innovative drugs which in turn is contributing towards the market growth.
 

By use, human use of mice model accounted for 80% share in the year 2018. Increasing utilization of mice models for understanding disorders such as cardiovascular diseases, cancer, and diabetes is aiding the expansion of the market.
 

Citing the end-use landscape, companies segment held 62.1% share in the mice model market in the year 2018 owing to increasing R&D activities in pharma and biotech industries. Surging number of pipeline drugs for animal testing is also facilitating the business outlook.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2419657/
 

As per the regional analysis, the report states that U.S. mice model industry is expected to grow with a CAGR of 8% during 2019-2025. Factors such as genetic resemblance to humans and rising adoption of mice models for research studies is contributing towards the popularity of the product across U.S.
 

The prominent companies operating in the mice model market are The Jackson Laboratory, TransViragen Inc., Transposagen Biopharmaceuticals Inc., Taconic Biosciences Inc., Janvier Labs, genOway, Envigo, and Charles River.


Frequently Asked Questions (FAQ) :

According to the report, rising adoption of mice in order to develop advanced vaccines is a key factor driving the mice model market growth. Mice model is the use of mice to study the development and occurrences of diseases as mice have a genetic formation similar to humans. Mice are also used in mechanistic analysis of human reproduction. Increasing number of testing procedures on mice in order to ensure safe use of drugs in humans are aiding the expansion of the market. Factors such as surging usage of mice for conducting research on cardiovascular diseases, autoimmune diseases and cancer are stimulating the industry outlook. Rising consumption rates of personalized medicines is leading to surging demand for customized humanized mice models. Rising number of pipeline drugs has increased animal testing instances, for authenticating the safety and efficacy of novel drugs, thereby boosting the growth of the market.
The CRISPER technology segment held 32.7% share in the mice model market in the year 2018. CRISPER technology based mice models offer benefits such as better efficiency, ease of use, cost-effectiveness, and time saving, thereby fueling the growth of the segment.
The report states that U.S. mice model industry is expected to grow with a CAGR of 8% during 2019-2025. Factors such as genetic resemblance to humans and rising adoption of mice models for research studies is contributing towards the popularity of the product across U.S.
he prominent companies operating in the mice model market are The Jackson Laboratory, TransViragen Inc., Transposagen Biopharmaceuticals Inc., Taconic Biosciences Inc., Janvier Labs, genOway, Envigo, and Charles River.